Skip to main content
. 2021 Jan 26;11:2229. doi: 10.1038/s41598-021-82055-0

Figure 3.

Figure 3

Antiviral evaluation using SARS-CoV-2 replicon. (A) Antiviral activity of remdesivir. The CHO-K1 cells electroporated with 5 μg of replicon RNA were seeded in a 96-well plate. The cells were treated immediately with 10-μM remdesivir or 0.2% DMSO. Luminescence was measured at 24 h post-treatment. The mean and standard error of two independent experiments are shown in this figure. A one-way ANOVA was performed to determine the statistical significance. A p-value less than 0.05 was considerd to be statistically significant. NS not significant. (B) Calculation of IC50 and CC50. The CHO-K1 cells electroporated with replicon RNA was seeded. The cells were immediately treated with remdesivir at indicated concentrations. Luminescence and cell viability were measured at 24 h post-treatment. IC50 and CC50 values were calculated by GraphPad software. The mean and standard error of two independent experiments are shown in this figure.